Our Pipeline

KYE is committed to bringing value to Canadians with medicines that fulfill clinically significant needs that have not been met in Canada. With a number of lead product candidates in psychiatry, vascular health, dermatology, immunology, and other therapeutic areas, KYE is poised to become a major contributor to improving the health of Canadians in a meaningful way in the near future. KYE also believes strongly in listening closely to Canadians to meet our commitment to fulfilling the unmet needs of both health care professionals and patients. If you currently are a patient or a health care professional experiencing sub-optimal care or lack of options in practice due to a specific medicine not being available in Canada, please contact us. It is our mission to evaluate all opportunities that will improve the lives of Canadians.

2021
Psychiatry
Q1
2021
2021
Cardiology
Q1
2021
2021
Psychiatry
Q2
2021
2021
Immunology
Q4
2021
2022
Cardiology
Q1
2022
2022
Pediatrics
Q2
2022
2023
Pediatrics
Q2
2023